Arthritis and other sequelae to intraperitoneally administered dextran in rats--relationship to molecular weight of the glucan
Hall, C.E.; Ayachi, S.; Hall, O.
Texas Reports on Biology and Medicine 29(3): 289-312
1971
ISSN/ISBN: 0040-4675 PMID: 5151787 Document Number: 31419
Document emailed within 1 workday
Related Documents
Poser, R.; Hirche, H. 1992: Randomized double-blind study of therapy of sudden deafness. Low molecular weight dextran + naftidrofuryl vs. low molecular weight dextran + placebo Hno 40(10): 396-399Feng, Y.; Zhang, J.; Li, S.; Liu, Y.; Zhang, Y.; Guo, Y.; Yang, M. 2017: Changes in nitric oxide, angiotensin Ⅱ angiopoietin-like protein 4 mRNA, neuregulin 1 mRNA, and platelet endothelial cell adhesion molecule-1 in rats with acute blood stasis induced by high-molecular-weight dextran Journal of Traditional Chinese Medicine 37(6): 846-853
Brossy, J.J.; Lewis, J.; Black, D. 1982: Low-molecular-weight dextran and puff-adder bites South African Medical Journal 62(11): 349-350
Wang, H.W. 1973: Low molecular weight dextran im epidemic hemorrhagic fever Zhonghua Yi Xue Za Zhi 6: 355-358
Tananov, A.T.; Zotikov, E.A.; Polushina, T.V.; Sirotkina, V.P. 1975: Comparative study of conglutinating properties of Soviet-made dextran of different molecular weight Problemy Gematologii i Perelivaniia Krovi 20(7): 59-60
Sukhanov, A.A.; Sukhanov, V.A. 1976: Use of law molecular weight dextran for prevention of thrombosis in surgical patients (review of the literature) Khirurgiia 1976(10): 133-135
Rossberg, G.; Krüger, E.C. 1977: The treatment of sudden deafness and Menière's disease with papaverin and low molecular weight dextran Laryngologie Rhinologie Otologie 56(2): 160-166
Matsuo, O.; Kawaguchi, T.; Kosugi, T.; Mihara, H. 1980: Effect of low molecular weight dextran sulphate on plasmin activity measured with S-2251 Acta Physiologica Latino Americana 30(3): 193-198
Evarts, C.M.; Feil, E.I. 1971: Thromboembolism after elective surgery of the hip. Detection, natural history, prophylaxis, and results with low molecular weight dextran Orthopedic Clinics of North America 2(1): 167-174
Garrett, K.O.; Pautler, S.V.; Johnson, P.C. 1993: The inability of low-molecular-weight dextran, aspirin, and prostaglandin E1 to inhibit monolayer platelet adhesion to polyethylene Journal of Laboratory and Clinical Medicine 122(2): 141-148
Moore, R.M.; Bertone, A.L.; Muir, W.W. 1996: Effect of high-molecular weight dextran macromolecules on low-flow ischemia and reperfusion of the large colon in horses American Journal of Veterinary Research 57(7): 1067-1073
Wintch, R.; James, P.M.; Turner, C.; Vargish, T.; Anderson, B.; Meredith, J.H. 1977: Canine kidney preservation: comparison of "intracellular", "extracellular," and high molecular weight dextran flushing solutions Southern Medical Journal 70(12): 1414-1417
Smith, E.B. 1976: A rationale for intraperitoneally administered antibiotic therapy Surgery Gynecology and Obstetrics 143(4): 561-564
Chan, T.C.; Coppoc, G.L.; Zimm, S.; Cleary, S.; Howell, S.B. 1988: Pharmacokinetics of intraperitoneally administered dipyridamole in cancer patients Cancer Research 48(1): 215-218
Speyer, J.L.; Collins, J.M.; Dedrick, R.L.; Brennan, M.F.; Buckpitt, A.R.; Londer, H.; DeVita, V.T.; Myers, C.E. 1980: Phase i and pharmacological studies of 5-fluorouracil administered intraperitoneally Cancer Research 40(3): 567-572
Couturaud, F.; Julian, J.A.; Kearon, C. 2001: Low molecular weight heparin administered once versus twice daily in patients with venous thromboembolism: a meta-analysis Thrombosis and Haemostasis 86(4): 980-984
Sasaki, T.; Abiko, N.; Uchida, H.; Tanaka, M.; Nitta, K.; Yoshioka, Y.; Nomura, H. 1983: Antitumor activity of tetrahydro-2-furanyl- and tetrahydro-2-pyranyl-glucans obtained by chemical modification of (1 leads to 3)-beta-D-glucan from Alcaligenes faecalis var. myxogenes IFO 13140 and its lower molecular weight glucans Cancer Treatment Reports 67(3): 275-280
Simon, S.; Schönné, F.I. 1975: Kinetics of changes in dextran concentration in the blood of rabbits following administration of dextran preparations of various molecular weights Acta Pharmaceutica Hungarica 45(3): 120-127
Chavali, S.R.; Barton, L.D.; Campbell, J.B. 1988: Immunopotentiation by orally-administered Quillaja saponins: effects in mice vaccinated intraperitoneally against rabies Clinical and Experimental Immunology 74(3): 339-343
Okamoto, K.; Nishikawa, K.; Seki, T.; Shibasaki, C.; Uchida, T.; Takahashi, K. 1985: The antitumor activity of intraperitoneally- or orally-administered etoposide in animals and its administration-schedule dependency Gan to Kagaku Ryoho. Cancer and ChemoTherapy 12(12): 2331-2337